Acquired Immunodeficiency SyndromeTreatment OutcomeDrugs, GenericAnti-Retroviral AgentsFoundationsHIV InfectionsAnti-HIV AgentsDrug CostsAntiretroviral Therapy, Highly ActiveDeveloping CountriesHealth Services AccessibilityBrazilPatient ComplianceOutcome Assessment (Health Care)CD4 Lymphocyte CountRetrospective StudiesPregnancy OutcomeFollow-Up StudiesPrognosisAntitubercular AgentsProspective StudiesTime FactorsDirectly Observed TherapyOutcome and Process Assessment (Health Care)Cognitive TherapyCohort StudiesRisk FactorsTreatment FailureSurvival AnalysisCombined Modality TherapySurvival RateSeverity of Illness IndexRecurrencePredictive Value of TestsTuberculosis, PulmonaryExtensively Drug-Resistant TuberculosisTuberculosis, Multidrug-ResistantRandomized Controlled Trials as TopicPregnancySubstance-Related DisordersMultivariate AnalysisBuprenorphineKaplan-Meier EstimateOpioid-Related DisordersQuality of LifePsychotherapySubstance Abuse Treatment CentersLogistic ModelsInfant, NewbornAge FactorsDrug Therapy, CombinationTuberculosisAlcoholismUnited StatesHospitals, Chronic DiseaseNeoplasm StagingRisk AssessmentPatient SatisfactionTemperanceAntineoplastic Combined Chemotherapy ProtocolsPsychiatric Status Rating ScalesRemission InductionPatient DropoutsCocaine-Related DisordersImplosive TherapyMethadoneLongitudinal StudiesPostoperative ComplicationsDisease-Free SurvivalClinical Trials as TopicDepressive Disorder, MajorReproducibility of ResultsIncidenceProportional Hazards ModelsRegression AnalysisDisease ProgressionResidential TreatmentGenotypeRetreatmentCoinfectionChi-Square DistributionMedication AdherenceEthambutolFirst AidBehavior TherapySex FactorsAnalysis of VarianceResearch DesignNeoplasm Recurrence, LocalPatient SelectionPilot ProjectsPrecursor Cell Lymphoblastic Leukemia-LymphomaOpiate Substitution TreatmentRegistriesRibavirinAntidepressive AgentsAcute DiseaseLength of StayPeer Review, Health CareMotivation